Pamidronate use in two cases of hypercalcaemia secondary to hyperparathyroidism
Weatherall, M.
New Zealand Medical Journal 105(942): 389
1992
ISSN/ISBN: 0028-8446 PMID: 1436853 Document Number: 402592
Document emailed within 1 workday
Related Documents
Weatherall, M. 1992: Pamidronate use in two cases of hypercalcaemia secondary to hyperparathyroidism New Zealand Medical Journal 105(942): 389Kotzmann, H.; Svoboda, T.; Bernecker, P.; Clodi, M.; Woloszczuk, W.; Niederle, B.; Waldhäusl, W.; Luger, A. 1994: Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism Wiener Klinische Wochenschrift 106(13): 422-425
Darcan, S.ük.; Coker, M.; Aydinok, Y.şi.; Gökşen, D.; Ozok, G. 2003: Persistent elevated serum levels of intact parathyroid hormone after reoperation for primary hyperparathyroidism and after pamidronate therapy Turkish Journal of Pediatrics 45(3): 269-272
Vestergaard, P.; Nielsen, L.R.; Mosekilde, L. 2006: Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism Ugeskrift for Laeger 168(1): 29-32
Sotorník, I.; Kocandrle, V. 1989: Personal experience with surgical treatment of hyperparathyroidism in chronic kidney failure. I. Etiopathogenesis of secondary hyperparathyroidism, preoperative findings, indications for parathyroidectomy Casopis Lekaru Ceskych 128(24): 742-747
Mysiak, W.; Stasiak, L.; Elwertowski, M.; Stopiński, M. 1991: Ultrasonic examination of the parathyroid glands, bone x-ray and calcium deposits of the eye in diagnosis of secondary hyperparathyroidism in light of 12 observed cases Polski Tygodnik Lekarski 46(43-44): 818-821
Kraj, M.; Pogłód, R.; Pawlikowski, J.; Maj, S.; Nasiłowska, B. 2000: Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. the results of the first 12 months of pamidronate therapy Acta Poloniae Pharmaceutica 57 Suppl: 113-116
Okamoto, T.; Ueno, T.; Morii, H. 1978: Secondary hyperparathyroidism Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1574-1575
Tahara, H. 2004: Hypertension secondary to hyperparathyroidism Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 3): 517-520
Locatelli, F.; Limardo, M.; Pontoriero, G. 2008: New approaches to treatment of secondary hyperparathyroidism Current Opinion in Investigational Drugs 9(4): 363-370
Fink, R.R. 1982: Secondary hyperparathyroidism--renal osteopathy Münchener Medizinische Wochenschrift 124(50): 64: 66
Leapman, S.B.; Filo, R.S.; Thomalla, J.V.; King, D. 1989: Secondary hyperparathyroidism. The role of surgery American Surgeon 55(6): 359-365
Weller, R.E.; Cliver, S. 1981: Canine renal secondary hyperparathyroidism Modern Veterinary Practice 62(2): 117-120
Imanishi, Y. 2017: Oral calcimimetics on secondary hyperparathyroidism of uremia Clinical Calcium 27(4): 561-566
Uda, S.; Yoshimura, A.; Sugenoya, Y.; Inui, K.; Iwasaki, S.; Taira, T.; Ideura, T. 1996: Role of apoptosis in the progression of secondary hyperparathyroidism Nihon Jinzo Gakkai Shi 38(8): 323-328
Nowak, Z.; Konieczna, M.; Saracyn, M.; Baczyński, D.; Wesolowski, P.; Waińkowicz, Z. 2008: Cinacalcet in the therapy of secondary hyperparathyroidism--own experiences Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 303-306
Cavallero, G.; Rossi, E.; Dealessi, M.; Testa, S.; Zanardi, F.; Leinati, A.; Summa, M. 1991: Primary and secondary hyperparathyroidism. Analysis of our results Minerva Chirurgica 46(9): 447-449
Rozhinskaia, L.Ia.; Smorshchok, V.N.; Artemova, A.M.; Rodina, L.F.; Makanin, M.A.; Lapshina, A.M.; Abrosimov, A.Iu. 2009: Recurring secondary hyperparathyroidism: case report Klinicheskaia Meditsina 87(7): 67-70
Castro, R.; Herman, A.; Ferreira, C.; Travassos, F.; Nunes-Azevedo, J.; Oliveira, M. 2002: RenaGel efficacy in severe secondary hyperparathyroidism Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 22(5): 448-455
Jensen, O.N. 1999: Prevalence of secondary hyperparathyroidism in patients aged 80 and over Ugeskrift for Laeger 161(16): 2362-2364